Sentinel Snaps up WellSpring Pharmaceutical
New York-based middle market PE firm Sentinel Capital Partners will acquire WellSpring Pharmaceutical Corp., a maker of specialty prescription and over the counter drugs. Ancor Capital Partners joined the PE firm in the deal.
7 November 2011•4 mins read
